Holen Sie sich die Stockscreener-App
31.94
4.24%
1.30
Handel nachbörslich:
31.95
0.010
+0.03%
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
19.47%
55.98
|
46.86 | 42.61 | 45.96 | 40.43 |
| Operating Income/Loss |
19.47%
-55.98
|
-46.86 | -42.61 | -45.96 | -40.43 |
| Income/Loss From Continuing Operations Before Tax |
23.50%
-50.22
|
-40.67 | -36.12 | -40.80 | -34.13 |
| Income/Loss From Continuing Operations After Tax |
23.51%
-50.23
|
-40.67 | -36.12 | -40.80 | -34.13 |
|
Net Income/Loss
|
23.48%
-50.22
|
-40.67 | -36.12 | -40.80 | -34.13 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.02%
1.0383
|
105.49 | 104.94 | 95.13 | 93.81 |
| Diluted Average Shares |
99.02%
1.0383
|
105.49 | 104.94 | 95.13 | 93.81 |
| Basic Earnings Per Share |
23.08%
-0.48
|
-0.39 | -0.34 | -0.43 | -0.36 |
| Diluted Earnings Per Share |
23.08%
-0.48
|
-0.39 | -0.34 | -0.43 | -0.36 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):